Press Release

MAXIPLUS MEDICAL & PHARMACEUTICAL’s press release

NEW 1 MAXIPLUS MEDICAL & PHARMACEUTICAL’s Haifa Advances into Brazil, the Largest Market in Latin America, with Marketing Authorization: 2020-0220

NEW 2 MAXIPLUS MEDICAL & PHARMACEUTICAL Begins Joint AI-based Oncology Drug Discovery Research with A2A Pharmaceuticals: 2020-0114

NEW 3 MAXIPLUS MEDICAL & PHARMACEUTICAL, World’s First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Maxiplus Infion.: 2020-0106

MAXIPLUS MEDICAL & PHARMACEUTICAL’s products Advances into Brazil, the Largest Market in Latin America, with Marketing Authorization 2020-02-20
MAXIPLUS MEDICAL & PHARMACEUTICAL Begins Joint AI-based Oncology Drug Discovery Research with A2A Pharmaceuticals 2020-01-14
MAXIPLUS MEDICAL & PHARMACEUTICAL, World’s First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Maxiplus Infion. 2020-01-06
MAXIPLUS MEDICAL & PHARMACEUTICAL Launches Networking Implanted Medical Devices in Isreal 2019-12-31
MAXIPLUS MEDICAL & PHARMACEUTICAL, acquired International Standards for Quality Management System: ISO 9001 and demonstrated the superiority of its own research and development. 2019-12-09
MAXIPLUS MEDICAL & PHARMACEUTICAL released a research result of an autoimmune disease candidate substance, ‘DWP212525’ for the first time in American College of Rheumatology. 2019-11-12
MAXIPLUS MEDICAL & PHARMACEUTICAL, established a difference in scar care effects by a medication timing based on a clinical research, ‘NABOTA.’ 2019-11-11
MAXIPLUS MEDICAL & PHARMACEUTICAL launches Medical Equipment X-ray generator Radiography Fluoroscopy, x-ray, miscellaneous, medical Diagnosis, medicine. 2019-10-28
MAXIPLUS MEDICAL & PHARMACEUTICAL presented the multiracial phase 1 clinical test results of ‘DWP14012,’ a drug for gastroesophageal reflux disease, at the United European Gastroenterology (UEG Week). 2019-10-24

Search